Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



Insulin producing cells transplanted into kidneys of diabetic mice

US researchers have created insulin-producing cells and successfully transplanted them in vivo into the kidneys of diabetic mice. In the image, light micrograph of insulin crystals

Source: Alfred Pasieka / Science Photo Library

Insulin producing cells were transplanted into the kidneys of diabetic mice, where they were able to secrete insulin

Type 1 diabetes is an autoimmune disease that leads to destruction of the pancreatic β-cells. A revolutionary new treatment may be on the horizon after US researchers managed to create human insulin-producing cells (IPCs) that were able to control glucose levels when transplanted in vivo.

Nicholas Zavazava, from the University of Iowa, and colleagues took induced pluripotent stem (iPS) cells from human skin cells and, using a series of pancreatic growth factors, caused them to differentiate into IPCs. The IPCs were then transplanted into the kidneys of diabetic mice, where they were able to secrete insulin and glucagon, to develop their own blood supply and to cause blood glucose levels in the mice to gradually decline.

“iPS cells might be a novel option for the treatment of type 1 diabetes,” the researchers conclude in PloS One (online, 28 January 2015)[1].

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067826

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.